Esomeprazole Dose and Symptom Resolution in Patients with Gastroesophageal Reflux Disease (GERD): Is There a Ceiling Effect? 2009 Presidential Poster

被引：0
|
作者：
Illueca, Marta [1 ]
Liu, Sherry [1 ]
Orlando, Roy [2 ]
机构：
[1] AstraZeneca LP, Wilmington, DE USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷
关键词：
D O I：
10.14309/00000434-200910003-00006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
6
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 50 条
  • [21] Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease
    PENG Sui XIONG Lishou XIAO Yinglian WANG Anjiang LIN Jinkun HU Pinjin and CHEN Minhu Division of Gastroenterology Hepatology the First Affiliated Hospital of Sun Yatsen University Guangzhou Guangdong China
    中华医学杂志（英文版）, 2010, (15) : 2012 - 2017
  • [22] Rabeprazole relieves symptom distress in patients with non-erosive gastroesophageal reflux disease (GERD).
    Siddique, R
    Sloan, S
    Zheng, M
    Bhattacharjya, A
    Johanson, J
    Farup, CE
    GASTROENTEROLOGY, 2000, 118 (04) : A1096 - A1096
  • [23] Symptom profiles and endoscopic findings in African-American patients with gastroesophageal reflux disease (GERD)
    Want, Sachin B.
    Rastogi, Amu
    Barisal, Ajay
    Hall, Sandy
    Mather, Sharad
    Sharma, Prateek
    GASTROENTEROLOGY, 2007, 132 (04) : A161 - A161
  • [24] Costs benefits with esomeprazole 20 mg "on-demand" treatment in gastroesophageal reflux disease (GERD) patients in Belgium
    Louis, E
    Urbain, D
    Deltenre, M
    Vandenhoven, G
    Duquenne, V
    Schockaert, B
    VALUE IN HEALTH, 2004, 7 (06) : 754 - 755
  • [25] RELAXATION TRAINING REDUCES SYMPTOM REPORTS AND ACID EXPOSURE IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS
    HAILE, JM
    BRADLEY, LA
    BAILEY, MA
    SCHAN, CA
    RICHTER, JE
    GASTROENTEROLOGY, 1993, 104 (04) : A1051 - A1051
  • [26] OMEPRAZOLE RESISTANCE IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    JUST, R
    GIDEON, RM
    CASTELL, D
    GASTROENTEROLOGY, 1994, 106 (04) : A101 - A101
  • [27] Pharmacokinetics of esomeprazole in adolescent patients aged 12 to 17 years inclusive with symptoms of gastroesophageal reflux disease (GERD)
    Zhao, J
    Li, JG
    Hamer, JE
    Andersson, T
    Illueca, M
    Lundborg, P
    GASTROENTEROLOGY, 2005, 128 (04) : A303 - A303
  • [28] Population pharmacokinetics of esomeprazole in adult patients with gastroesophageal reflux disease
    Li, J
    Lind, T
    Tzeng, T
    Birmingham, B
    Zhao, J
    Andersson, T
    Martin, P
    Lundborg, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P92 - P92
  • [29] Validation of a nocturnal gastroesophageal reflux disease (GERD) symptom severity and impact instrument
    Harding, G.
    Roberts, L.
    Spiegel, B. M.
    Mody, R. R.
    Revicki, D.
    Kahrilas, P. J.
    Camilleri, M. L.
    Walter, K.
    VALUE IN HEALTH, 2008, 11 (03) : A90 - A90
  • [30] The effect of sleep duration on symptoms perception of patients with gastroesophageal reflux disease (GERD)
    Green, C
    Dekel, R
    Quan, S
    Stephen, G
    Fass, R
    GASTROENTEROLOGY, 2003, 124 (04) : A255 - A256
12345